Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dscCfaE + LTR192G Vaccine against ETEC
NCT01922856Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Sep 2013
- Primary completion
- Feb 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant fimbrial adhesin dscCfaE in enterotoxigenic Escherichia coli infection, diarrhea, sponsored by U.S. Army Medical Research and Development Command. Started Sep 2013; status: completed.
02
Drugs
recombinant fimbrial adhesin dscCfaE
03
Conditions
enterotoxigenic Escherichia coli infectiondiarrhea
Beyond the preview
Go deeper on NCT01922856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01922856.